期刊文献+

胃癌多药耐药相关蛋白表达的临床分析 被引量:3

Clinical Analysis of Expression of Multidrug Resistance-associated Protein in Gastric Carcinoma
在线阅读 下载PDF
导出
摘要 背景:胃癌对化疗药物原发或继发不敏感可致肿瘤多药耐药。目的:探讨胃癌组织中多药耐药相关蛋白P糖蛋白(P-gp)、谷胱甘肽S-转移酶(GST)-π、Bcl-xL的表达及其意义。方法:收集胃癌手术标本113例,每例标本选取肿瘤组织、距病灶5 cm以上的正常胃黏膜组织各1块。以免疫组化法检测多药耐药相关蛋白P-gp、GST-π、Bcl-xL的定位和表达,并与胃癌主要临床病理特征行相关性分析。结果:胃癌组织的P-gp、GST-π、Bcl-xL阳性表达率(48.7%对5.3%,P<0.05;62.8%对25.7%,P<0.05;83.2%对23.0%,P<0.05)和高表达率(18.6%对0%,P<0.05;23.9%对0%,P<0.05;71.7%对0%,P<0.05)均明显高于正常胃黏膜组织,胃癌组织P-gp、GST-π、Bcl-xL三者间表达呈正相关(P<0.05)。胃癌组织GST-π、Bcl-xL阳性表达与肿瘤组织分化程度呈正相关(P<0.05).胃癌组织P-gp、GST-π、Bcl-xL表达与患者的性别、年龄、浸润深度、淋巴结转移和临床分期均不相关(P>0.05)。结论:胃癌组织多药耐药相关蛋白P-gp、GST-π、Bcl-xL表达与胃癌的发生相关,且肿瘤组织GST-π、Bcl-xL表达与分化程度呈正相关,可作为判断胃癌患者预后的指标。 Background: The primary or secondary non-sensitivity of gastric cancer to chemotherapy induces muhidrug resistance. Aims: To investigate the expressions of muhidrug resistance-associated protein P-glycoprotein (P-gp), glutathione S-transferase (GST)-π and Bcl-xL in tissues of gastric cancer and its significance. Methods: Cancerous specimens and normal gastric mueosal specimens (more than 5 cm away from the cancerous lesions) were obtained from 113 samples with gastric cancer. Immunohistochemical staining was used to detect the location and expression of P-gp, GST-π and Bcl-xL, and their relationships with major clinicopathological features of gastric cancer were analyzed. Results: The positive expression rates (48,7% vs. 5.3%, P〈0.05; 62.8% vs. 25.7%, P〈0.05; 83.2% vs. 23.0%, P〈0.05) and high expression rates (18.6% vs. 0%, P〈0.05; 23.9% vs. 0%, P〈0.05; 71.7% vs. 0%, P〈0.05) of P-gp, GST-π and Bcl-xL in gastric cancerous tissues were significantly higher than those in normal gastric mucosa. The expressions of P-gp, GST-π and Bcl-xL in cancerous tissues were positively correlated with each other (P〈0.05). The expressions of GST-π and Bcl-xL in cancerous tissues were positively correlated with the differentiation of tumor (P〈0.05), while no correlations were found between P-gp, GST-π and Bcl-xL expressions and patients' gender, age, depth of infiltration, lymph node metastasis or clinical stage (P〉0.05). Conclusions: The expressions of multidrug resistance-associated protein P-gp, GST-π and Bcl-xL are related with gastric carcinogenesis. The expressions of GST-π and Bcl-xL in cancerous tissues are positively correlated with the differentiation of tumor, and could be used as prognostic factors in patients with gastric cancer.
出处 《胃肠病学》 2011年第5期293-297,共5页 Chinese Journal of Gastroenterology
关键词 胃肿瘤 多药耐药相关蛋白质类 P糖蛋白 谷胱甘肽S-转移酶pi bcl-X蛋白质 Stomach Neoplasms Multidrug Resistance-Associated Proteins P-Glycoprotein Glutathione S-Transferase pi bcl-X Protein
  • 相关文献

参考文献19

  • 1Takara K, Sakaeda T, Okumura K. An update on overcoming MDRl-mediated muhidrug resistance in cancer chemotherapy. Curr Pharm Des, 2006, 12 (3): 273-286.
  • 2Takechi T, Koizumi K, Tsujimoto H, et al. Screening of differentially expressed genes in 5-fluorouracil-resistant human gastrointestinal tumor cells. Jpn J Cancer Res, 2001, 92 (6): 696-703.
  • 3Depeille P, Cuq P, Passagne I, et al. Combined effects of GSTP1 and MRP1 in melanoma drug resistance. Br J Cancer, 2005, 93 (2): 216-223.
  • 4Minn A J, Rudin CM, Boise LH, et al. Expression of bcl- xL can confer a muhidrug resistance phenotype. Blood, 1995, 86 (5): 1903-1910.
  • 5Simonian PL, Grillot DA, Nunez G. Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death. Blood, 1997, 90 (3): 1208-1216.
  • 6Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol, 2005, 205 (2): 275-292.
  • 7Arancia G, Molinari A, Calcabrini A, et al. Intracellular P-glyeoprotein in multidrug resistant tumor cells. Ital J Anat Embryol, 2001, 106 (2 Suppl 1): 59-68.
  • 8Miletti-Gonzalez KE, Chen S, Muthukumaran N, et al. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res, 2005, 65 (15): 6660-6667.
  • 9Ruefli AA, Tainton KM, Darcy PK, et al. P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation. Cell Death Differ, 2002, 9 (11): 1266-1272.
  • 10谭晖,李一琴,张志伟,周秀田,曾希,曹建国.5-Fu抗结肠癌作用与细胞凋亡及P-gp蛋白表达的关系[J].南华大学学报(医学版),2005,33(3):311-313. 被引量:4

二级参考文献25

  • 1曹建国,廖端芳,陈剑雄,朱炳阳,张德菊,唐小卿.琼脂培养MTT法测定混合培养HeLa细胞和人胚肺纤维母细胞药物敏感性[J].中国肿瘤临床,1995,22(7):495-499. 被引量:21
  • 2Kaufmann SH, Desnoyers S, Ottaviano Y, et al.Specific proteolytic cleavage of poly (ADP-rbose) polymerase: an early marker of claemotherapy-induced apoptosis [ J ], Cancer Res,1993,53(17) :3976 - 3985.
  • 3Johnstone RW, Cretney E, Smyth MJ. P- glycoprotein protects lemnemia ceils against caspase-dependent, but not caspase - independent cell death[J]. Blood, 1999,93(3) : 1075 - 1085.
  • 4Sadanand V, Kankesan J, Yusuf A. Effect of PSC 833, a potent inhibitor of P - glyeoprotein, on the growth of astroeytoma cells in vitro [ J ]. Cancer Lett, 2003,198 ( 1 ) : 21 -27.
  • 5Drach J, Gsur A, Hamilton G, et al. Involvement of Pglycoprotein in the transmembrance thansport of interleukin-2(IL - 2), IL - 4, and interferon - gamma in normal human T lymphoeytes[J]. Blood, 1996, 88(5): 1747 -1754.
  • 6Li P, Nijhawan D,Budihardjo I, et al. Cytochrome C and dATP- dependent formation of Apaf- 1/caspase - 9complexinitiates an apoptotie protease cascade [ J ]. Cell,1997,91 (4) :479 - 489.
  • 7Hu XM, Hirano T, Oka K. Arsenic trioxide induces apoptosis in cells of MOLT- 4 and its daunorubicin - resistant cell line via depletion of intraceUular glutathione, disruption of mitoehondrial membrane potential and activation of caspase - 3[J]. Cancer Chemother Pharmaco1,2003,52(1):47-58.
  • 8Zhu H,Zhang L,Huang X,et al.Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor Ithrough distinct mechanisms[J].Mol Ther,2004,9(5):666-673.
  • 9Maurer CA,Friess H,Buhler SS,et al.Apoptosis inhibiting factor Bcl-xL might be the crucial member of the Bcl-2 gene family in colorectal cancer[J].Dig Dis Sci,1998,43(12):2641-2648.
  • 10Hayward RL,Macpherson JS,Cummings J,et al.Antisense Bclxl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells,enhancing global cytotoxicity[J].Clin Cancer Res,2003,9(7):2856-2865.

共引文献24

同被引文献31

  • 1李春艳,崔泽实,卢瑶,张莹,高建,王恩华.β-连环素/T细胞因子4信号通路在非小细胞肺癌中的研究[J].中华病理学杂志,2005,34(9):599-600. 被引量:10
  • 2关云艳,欧希龙,郭庆明,颜芳.P-gp,ToPoⅡ和GST-π在胃癌组织中的表达及与预后的关系[J].世界华人消化杂志,2006,14(35):3371-3376. 被引量:21
  • 3Ferlay J,Soerjomataram I, Dikshit R,et al. Cancer incidence and mortality worldwide: sources, methods and maj or patterns in GLOBOCAN 2012 [J]. Int J Cancer,2015,136(5) :E359- E386.
  • 4Engstrom PF,Arnoletti JP,Benson AB,et al. NCCN Clinical Practice Guidelines in Oncology: colon cancer [J]. J Natl Compr Cane Netw,2009,7(8) :778-831.
  • 5Foo J, Michor F. Evolution of acquired resistance to anti- cancer therapy [J]. J Theor Biol,2014,355:10-20.
  • 6Kessenbrock K, Plaks V, Werb Z, et al. Matrix metallopro- teinases: regulators of the tumor microenvironment [J]. Cell, 2010,141(1) :52-67.
  • 7MacDonald BT,Tamai K, He X. Wnt/beta-catenin signaling: components,mechanisms,and diseases [J]. Dev Ce11,2009, 17 (1) :9-26.
  • 8Meinhardt G, Haider S, Haslinger P, et al. Wnt-dependent T-cell factor-4 controls human etravillous trophoblast motility [J].Endocrinology, 2014,155(5) : 1908-1920.
  • 9Potocnik U, Ravnik-Glavac M, Glavac D,et al. Functional MDR1 polymorphisms (G2677T and C3435T) and TCF4 mutations in colorectal tumors with high microsatellite instability [J]. Cell Mol Biol Lett, 2002,7(1) :92-5.
  • 10Samanian S, Mahjoubi F, Mahjoubi Bet al. MDR1 gene polymorphisms: possible association with its expression and clinicopathology characteristics in colorectal cancer patients [J]. Asian Pac J Cancer Prev, 2011,12 (11) : 3141- 3145.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部